Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection

J Infect Dis. 2008 May 15;197(10):1369-77. doi: 10.1086/587488.

Abstract

Background: Prolonged coinfection with GB virus C (GBV-C) has been associated with improved survival in human immunodeficiency virus (HIV)-infected adults. We investigated whether maternal or infant GBV-C infection was associated with mother-to-child transmission (MTCT) of HIV-1 infection.

Methods: The study population included 1364 HIV-infected pregnant women enrolled in 3 studies of MTCT of HIV in Bangkok, Thailand (the studies were conducted from 1992-1994, 1996-1997, and 1999-2004, respectively). We tested plasma collected from pregnant women at delivery for GBV-C RNA, GBV-C antibody, and GBV-C viral genotype. If GBV-C RNA was detected in the maternal samples, the 4- or 6-month infant sample was tested for GBV-C RNA. The rates of MTCT of HIV among GBV-C-infected women and infants were compared with the rates among women and infants without GBV-C infection.

Results: The prevalence of GBV-C RNA in maternal samples was 19%. Of 245 women who were GBV-C RNA positive, 101 (41%) transmitted GBV-C to their infants. Of 101 infants who were GBV-C RNA positive, 2 (2%) were infected with HIV, compared with 162 (13%) of 1232 infants who were GBV-C RNA negative (odds ratio [OR] adjusted for study, 0.13 [95% confidence interval {CI}, 0.03-0.54]). This association remained after adjustment for maternal HIV viral load, receipt of antiretroviral prophylaxis, CD4(+) count, and other covariates. MTCT of HIV was not associated with the presence of GBV-C RNA (adjusted OR [aOR], 0.94 [95% CI, 0.62-1.42]) or GBV-C antibody (aOR, 0.90 [95% CI, 0.54-1.50]) in maternal samples.

Conclusions: Reduced MTCT of HIV was significantly associated with infant acquisition of GBV-C but not with maternal GBV-C infection. The mechanism for this association remains unknown.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Anti-Retroviral Agents / therapeutic use
  • Antibodies, Viral / blood
  • CD4 Lymphocyte Count
  • Child
  • Female
  • Flaviviridae Infections / transmission*
  • Flaviviridae Infections / virology*
  • GB virus C / classification
  • GB virus C / genetics
  • GB virus C / isolation & purification*
  • Genotype
  • HIV / isolation & purification*
  • HIV Infections / drug therapy
  • HIV Infections / transmission*
  • HIV Infections / virology
  • Hepatitis, Viral, Human / transmission*
  • Hepatitis, Viral, Human / virology*
  • Humans
  • Infant
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical*
  • Mothers
  • Pregnancy
  • Pregnancy Complications, Infectious
  • Prevalence
  • RNA, Viral / blood
  • Thailand
  • Viral Load

Substances

  • Anti-Retroviral Agents
  • Antibodies, Viral
  • RNA, Viral